Apollomics director granted 2,000 stock options

Apollomics director Tsai Hsien-Shu reported RSU vesting and a new stock option grant tied to future service-based vesting.

Rhea-AI Filing Summary

Apollomics Inc. (APLM) director Tsai Hsien-Shu reported equity compensation activity. On September 15, 2026, 500 Restricted Stock Units vested and were settled into 500 Class A Ordinary Shares, bringing the director’s direct holdings to 2,000 Class A Ordinary Shares. On September 14, 2026, the director also received a stock option grant for 2,000 Class A Ordinary Shares at an exercise price of $23.18 per share, expiring September 14, 2036, under the Apollomics Inc. 2023 Incentive Award Plan. The option vests 50% on March 14, 2027 and 50% on September 14, 2027, subject to continued service. No Rule 10b5-1 trading plan is reported.

Insider Trade Summary

500 shares exercised/converted

Exercise 3 txns

Insider TSAI HSIEN-SHU

Role Director

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Units F1, F3	500	$0.00	$0.00
Exercise	CLASS A ORDINARY SHARES	500	$0.00	$0.00
Grant/Award	Stock Option (Right to Buy) F2	2,000	$0.00	$0.00

Holdings After Transaction: Stock Option (Right to Buy) — 2,000 contracts (Direct); Restricted Stock Units — 500 contracts (Direct); CLASS A ORDINARY SHARES — 2,000 shares (Direct)

Footnotes (3)

1. F1. Each restricted stock unit represents a contingent right to receive one Class A Ordinary Share
2. F2. The stock option was granted under the Apollomics Inc. 2023 Incentive Award Plan on September 14, 2026. The option vests and becomes exercisable over a one-year period: fifty percent (50%) of the shares subject to the option vest on March 14, 2027 (six months from the grant date), and the remaining fifty percent (50%) vest on September 14, 2027 (twelve months from the grant date), subject to the reporting person's continued service to the Issuer through each applicable vesting date.
3. F3. RSUs were granted and previously reported on a Form 3 filed March 18, 2026 and a Form 3/A filed April 14, 2026. Of the initial RSU grant, 500 shares vested on each of February 9, 2026, March 15, 2026, June 15, 2026, and September 15, 2026. This transaction represents the vesting of 500 RSUs on September 15, 2026.

Key Figures

RSUs vested and converted: 500 shares Shares held after RSU vesting: 2,000 Class A Ordinary Shares Stock options granted: 2,000 options +4 more

7 metrics

RSUs vested and converted 500 shares Restricted Stock Units vested and settled into Class A Ordinary Shares on September 15, 2026

Shares held after RSU vesting 2,000 Class A Ordinary Shares Direct holdings following the September 15, 2026 share issuance

Stock options granted 2,000 options Stock Option (Right to Buy) grant on September 14, 2026 under the 2023 Incentive Award Plan

Stock option exercise price $23.18 per share Exercise price for 2,000 stock options granted September 14, 2026

Option expiration date September 14, 2036 Expiration of the 2,000 stock options granted to the director

First vesting tranche 50% of options Vests and becomes exercisable on March 14, 2027, six months from grant date

Second vesting tranche 50% of options Vests and becomes exercisable on September 14, 2027, twelve months from grant date

Key Terms

Restricted Stock Units, Stock Option (Right to Buy), Incentive Award Plan, vesting

4 terms

Restricted Stock Units financial

"Each restricted stock unit represents a contingent right to receive one Class A"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Stock Option (Right to Buy) financial

"Stock Option (Right to Buy) grant of 2,000 derivative securities"

Incentive Award Plan financial

"The stock option was granted under the Apollomics Inc. 2023 Incentive Award Plan"

An incentive award plan is a formal program that rewards employees, executives, or directors with cash, stock, options, or other pay when the company meets set goals or performance targets. Like a sales commission or a loyalty program that pays out when you hit milestones, it’s designed to align staff behavior with company objectives; investors care because it affects a company’s costs, share count (dilution), leadership incentives, and long-term value creation.

vesting financial

"fifty percent (50%) of the shares subject to the option vest on March 14, 2027"

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What equity transactions did Apollomics (APLM) director Tsai Hsien-Shu report on this Form 4?

The director reported vesting of 500 RSUs into 500 Class A Ordinary Shares on September 15, 2026 and a grant of stock options for 2,000 Class A Ordinary Shares on September 14, 2026, both held directly.

How many Apollomics (APLM) Class A Ordinary Shares does the director hold after these transactions?

After the RSU vesting and share settlement, the director holds 2,000 Class A Ordinary Shares directly, as reported in the Form 4 for the September 15, 2026 transaction.

What are the key terms of the new stock option grant reported for APLM?

The director received 2,000 stock options for Class A Ordinary Shares with an exercise price of $23.18 per share, expiring on September 14, 2036, granted under the Apollomics Inc. 2023 Incentive Award Plan.

When do the new Apollomics (APLM) stock options vest for the director?

The stock options vest over one year: 50% on March 14, 2027 and the remaining 50% on September 14, 2027, subject to the director’s continued service to Apollomics Inc. through each vesting date.

What does the RSU transaction reported by Apollomics (APLM) represent?

The RSU transaction represents the vesting of 500 RSUs on September 15, 2026, each RSU being a contingent right to receive one Class A Ordinary Share. These RSUs were part of an earlier grant previously reported on Form 3 and Form 3/A.

Was the Apollomics (APLM) director’s Form 4 trading under a Rule 10b5-1 plan?

No. The filing’s Rule 10b5-1 checkbox is not checked, and the footnotes do not describe a trading plan, so no Rule 10b5-1 plan is reported for these transactions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/17/2026 - 08:48 PM Accepted by SEC EDGAR 09/17/2026 - 08:47 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

TSAI HSIEN-SHU

(Last) (First) (Middle)

668 ARROW GRAND CIR. SUITE 206

(Street)

COVINA CALIFORNIA 91772

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Apollomics Inc. [ APLM ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/14/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
CLASS A ORDINARY SHARES	09/15/2026		M		500	A	$0	2,000	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$23.18	09/14/2026		A		2,000		(2)	09/14/2036	CLASS A ORDINARY SHARES	2,000	$0	2,000	D
Restricted Stock Units	(1)	09/15/2026		M			500	(3)	(3)	CLASS A ORDINARY SHARES	500	$0	500	D

Explanation of Responses:

1. Each restricted stock unit represents a contingent right to receive one Class A Ordinary Share

2. The stock option was granted under the Apollomics Inc. 2023 Incentive Award Plan on September 14, 2026. The option vests and becomes exercisable over a one-year period: fifty percent (50%) of the shares subject to the option vest on March 14, 2027 (six months from the grant date), and the remaining fifty percent (50%) vest on September 14, 2027 (twelve months from the grant date), subject to the reporting person's continued service to the Issuer through each applicable vesting date.

3. RSUs were granted and previously reported on a Form 3 filed March 18, 2026 and a Form 3/A filed April 14, 2026. Of the initial RSU grant, 500 shares vested on each of February 9, 2026, March 15, 2026, June 15, 2026, and September 15, 2026. This transaction represents the vesting of 500 RSUs on September 15, 2026.

	/s/ Alison M. Pear, Attorney-In-Fact	09/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)